EN21-01, A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of 80 mg daily of NRD135S.E1 Versus Placebo in Adult and Elderly Participants with Painful Diabetic Peripheral Neuropathy (SERENDIPITY-1)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/2211/29/23

Funding

  • Massachusetts General Hospital (MG TASK ORDER 2 Mod 1 // 1OT2NS122680-01)
  • National Institute of Neurological Disorders and Stroke (MG TASK ORDER 2 Mod 1 // 1OT2NS122680-01)